Tuesday, March 31, 2009
CT Scanner
No. 6872: MARCONI 2000 MX8000 4 Slice with Low Slice Count on Tube CT Scanner
Starting Bid: U.S.$18000.00 - Reserve not met
This item will not be sold if the Reserve price is not met.
(Purchase It! U.S.$52000.00) Learn more
"Purchase It!" disappears one day before
the close of auction or when the reserve is met.
Time Left: 15 days, 4 hours +
Location: IL, USA
Bid Closes: Apr 15 - 4:00pm EDT
Manufacturer: MARCONI
Model: 2000 MX8000 4 Slice with Low Slice Count on Tube
Email the Seller
Forward to a friend
Seller's
Rating:
(2 votes)
What You Are Bidding On:
You are bidding on a 2000 Marconi MX8000 4 Slice CT Scanner w/ Low Slice Count on Tube:
The Tube was installed Oct. 29 2008, and as of 3-12-09, it has 13913 slices on it.
The Date of Manufacture is July 2000.
Product version 2.64.
The system does not have the standard console work desk as you will be able to see in the last two photos.
The system has a water circulator, but does not have a water chiller. The system was cooled by the Hospital water supply.
The system has a "Teal" power conditioner.
The options are:
Viewer
MPR
3D
Angio
MIP
Denta CT
Master Match
Time Lapse
Combine Images
Voyager
4-D Angio
Heart
Beat-CS
Function CT
Q-CTA
Master Look
Stereotaxis
MRI Normalization
Offline Recon.
Condition:
The equipment is installed and operational, is in clinical use and is currently covered by an OEM service contract.
Inspection:
You are free to inspect this equipment but if you want to inspect the equipment please do so before you bid. If you would like to arrange to inspect this equipment click on "Email Seller" above.
The equipment is located in Illinois.
Available:
The equipment will be available immediately upon receipt of payment in full.
Warranty:
This equipment is offered in accordance with the "Auction Terms" and "Legal Notice" of www.dotmed.com. No warranty is expressed or implied, including any warranty of merchantability or fitness for a particular purpose. All equipment is sold "as is" and "where is".
Terms:
The Successful Bidder agrees to remit payment in full within 48 hours of the Auction's close.
If the Successful Bidder fails to remit payment according to the schedule described above, then the equipment will be sold to the next highest Bidder.
Deinstallation, Packing, Crating and Transportation will be paid by the Successful Bidder.
This unit will be deinstalled on March 19th.
Title will transfer from the Seller to the Successful Bidder upon payment in full.
Monday, March 30, 2009
Cerebrum,Cerebellum,Brain Stem
Cerebrum - The cerebrum is the largest part of the brain. It is at the top of the brain. It uses information from our senses to tell us what is going on around us and tells our body how to respond. It controls reading, thinking, learning, speech, and emotions.
The cerebrum is divided into the left and right cerebral hemispheres, which control separate activities. The right hemisphere controls the muscles on the left side of the body. The left hemisphere controls the muscles on the right side of the body
Cerebellum - The cerebellum is under the cerebrum at the back of the brain. The cerebellum controls balance and complex actions like walking and talking.
Brain Stem - The brain stem connects the brain with the spinal cord. It controls hunger and thirst. It also controls breathing, body temperature, blood pressure, and other basic body functions.
What is the brain?
The brain is a soft, spongy mass of tissue. It is protected by the bones of the skull and three thin membranes called meninges. Watery fluid called cerebrospinal fluid cushions the brain. This fluid flows through spaces between the meninges and through spaces within the brain called ventricles.
A network of nerves carries messages back and forth between the brain and the rest of the body. Some nerves go directly from the brain to the eyes, ears, and other parts of the head. Other nerves run through the spinal cord to connect the brain with the other parts of the body. Within the brain and spinal cord, glial cells surround nerve cells and hold them in place.
The brain directs the things we choose to do (like walking and talking) and the things our body does without thinking (like breathing). The brain is also in charge of our senses (sight, hearing, touch, taste, and smell), memory, emotions, and personality.
The three major parts of the brain control different activities:
Sunday, March 29, 2009
X-ray Generator
Matsusada's high quality and reliable X-ray generators will satisfy your requirements for your OEM or laboratory applications. From this page you can access our full range of products and find the x-ray generator which best suits your application.
Should you need specifications which are not covered by our standard products, we are able to respond quickly and efficiently to your requirements and thereby to reduce your development cycles.
X-ray generator Selection Guide
You can browse the fully detailed x-ray generator product lineup
High Voltage Power Supply
Matsusada's high quality and reliable high voltage sources will satisfy your requirements for your OEM or laboratory applications. From this page you can access our full range of hv products and find the high voltage power supply which best suits your application.
Should you need specifications which are not covered by our standard high voltage products, we are able to respond quickly and efficiently to your requirements and thereby to reduce your development cycles.
High Voltage Power Supply Selection Guide
You can browse the fully detailed high voltage power supply product lineup.
X-ray Non Destructive Test (NDT) System
Matsusada's high quality and reliable X-ray inspection systems will satisfy your requirements for your x-ray non destructive testing. From this page you can access our full range of products and find the x-ray non destructive test systems which best suits your application.
Should you need specifications which are not covered by our standard products, we are able to respond quickly and efficiently to your requirements and thereby to reduce your development cycles.
HIV Testing
More than 20 percent of all Americans with HIV do not know they are infected, and many of them pass on the virus to others. The best way to protect yourself and your partners is to get tested for HIV. The following links provide useful information about testing.
Myths and Truths About HIV Testing (PDF)
Are you positive you’re negative? This booklet dispels many of the common misconceptions about the AIDS epidemic and HIV testing.
A Practical Guide to Getting Tested for HIV
This page explains who should get tested for HIV, how the test works, and what the results mean.
.
Where Can I Get Tested?
Search for an HIV testing site near you and link to additional HIV/AIDS resources.
Donate
Apply
Advocate
Participate
Stem Cell Move Heralds Hopeful New Era for Biomedical Research and for AIDS
March 9, 2009—President Obama’s removal of the ban on federal funding of embryonic stem cell research signals a hopeful new era for medical research in general, and AIDS in particular. Of equal importance, it is a concrete example of the statement President Obama made in his inaugural address that he will “restore[s] science to its rightful place.”
Stem cell research could ultimately benefit people suffering from a host of disorders, including Alzheimer’s disease, Parkinson’s, diabetes, stroke, spinal cord injury, and rheumatoid arthritis. Its promise extends to HIV/AIDS, a global epidemic that has already killed more than 25 million people worldwide.
In terms of AIDS, last year a group of physicians from Berlin reported on an HIV-positive man who developed acute leukemia. In an attempt to cure his leukemia he underwent a stem cell transplant. This is usually standard treatment in such cases, but his transplant had a unique twist. Rather than simply using the best match among available stem cell donors, his physicians also screened donors for a natural genetic mutation, one that renders a person resistant to infection by the most common forms of HIV. Now off all anti-HIV drugs for over two years, this man has no detectable signs of HIV or leukemia.
This first documented case of a functional cure for AIDS offers a startling illustration of the potential of stem cell-based therapies. It is not practical to search for such special mutations among stem cell donors and these mutations do not exist among African-Americans or Asians. But the potential to use embryonic stem cells – the ones covered by the former ban – to engineer these mutant cells to be used in such treatments offers new hope for people with the disease.
“There are still many challenges to be overcome and much research to be done before stem cells could be considered as a treatment or a cure for HIV/AIDS,” said Kevin Robert Frost, chief executive officer of amfAR, The Foundation for AIDS Research. “But as a result of President Obama’s action today, that research might actually see the light of day.”
The President’s executive order comes at an opportune time for researchers, who will be able to apply for a portion of the $20 billion in supplemental funding for the National Institutes of Health that was included in the economic recovery package.
“Science offers our best hope for bringing the global HIV/AIDS epidemic to an end,” said Susan Blumenthal, M.D., M.P.A., amfAR’s senior policy and medical advisor and former U.S. assistant surgeon general. “And when science can proceed without political interference and policy is driven by scientific evidence, there is hope for a healthier future, including reaching the time when we might live in a world without AIDS.”
Dr. Piot: Ask!
First of all, there are populations in India and China with very high HIV prevalence rates—among them sex workers in some areas in Karnataka and Andhra Pradesh in India, and injecting drug users all over China and East Asia. We're also seeing new, very rapidly rising epidemics among gay men and men who have sex with men [MSM].
India's overall prevalence rate is relatively low, which gives the impression that there's no problem, but HIV doesn't have a normal distribution in the statistical sense. As I said, it's concentrated among groups such as MSM, sex workers, and injecting drug users, and there the numbers are bad. In Asia, we need to take a long view of the epidemic. The growth of the epidemic in Asia has been slower than we anticipated, that's true, and we haven't gone into an African type of scenario in the short term. But with a denominator of one-third of the world's population, one percent in China is 13 million people and 10 million in India—more than the total population of some African countries.
One of the lessons that we've learned about AIDS is that we must expect surprises. The new epidemics among MSM all over East and Southeast Asia are a surprise but they shouldn't be. What I think is key is that the response to AIDS in both India and China has been quite good, after initial denial and hesitation. Who would have thought even five years ago that China would now have maybe 500 methadone clinics? In India, these clinics have had real, measurable results. The evolution of the AIDS epidemic is something that depends on many complex issues, one being the political context.
An Interview with Peter Piot
An Interview with Peter Piot—Change at UNAIDS: Peter Piot Moves On
March 2009—Lauded for his work as a scientist, physician, and public health leader, Dr. Peter Piot stepped down as executive director of UNAIDS in December 2008. He had been at its helm since the founding of UNAIDS in 1995. Dr. Piot is credited with co-discovering the Ebola virus in 1976, and he is widely recognized for having established the foundation of our understanding of AIDS in Africa. In this interview, Dr. Piot reflects on his tenure at UNAIDS, discusses the impact of the global recession on HIV/AIDS, and considers the direction of the epidemic in Asia and around the world.
March 2009—Lauded for his work as a scientist, physician, and public health leader, Dr. Peter Piot stepped down as executive director of UNAIDS in December 2008. He had been at its helm since the founding of UNAIDS in 1995. Dr. Piot is credited with co-discovering the Ebola virus in 1976, and he is widely recognized for having established the foundation of our understanding of AIDS in Africa. In this interview, Dr. Piot reflects on his tenure at UNAIDS, discusses the impact of the global recession on HIV/AIDS, and considers the direction of the epidemic in Asia and around the world.
Therapeutics Research, Education, and AIDS Training in Asia
TREAT Asia (Therapeutics Research, Education, and AIDS Training in Asia) is a network of clinics, hospitals, and research institutions working with civil society to ensure the safe and effective delivery of HIV/AIDS treatments throughout Asia and the Pacific. Facilitated by amfAR, TREAT Asia seeks to strengthen HIV/AIDS care, treatment, and management skills among health care professionals through education and training programs developed by experts in the region.
Around the Globe
Worldwide, women constitute half of all people living with HIV/AIDS.
Globally and in every region, more adult women (15 years or older) than ever before are now living with HIV.
Women are at least twice as likely to acquire HIV from men during sexual intercourse than vice versa.
Only 20% of young women aged 15 to 24 correctly identify ways of preventing HIV transmission and reject major misconceptions about HIV transmission.
In low- and middle-income countries, only one-third of pregnant women are currently offered services to prevent mother-to-child transmission of HIV.
In Sub-Saharan Africa, women constitute 59% of all people living with HIV/AIDS. Among young people aged 15-24, the HIV prevalence rate for young women is almost three times higher than the rate among young men.
Globally and in every region, more adult women (15 years or older) than ever before are now living with HIV.
Women are at least twice as likely to acquire HIV from men during sexual intercourse than vice versa.
Only 20% of young women aged 15 to 24 correctly identify ways of preventing HIV transmission and reject major misconceptions about HIV transmission.
In low- and middle-income countries, only one-third of pregnant women are currently offered services to prevent mother-to-child transmission of HIV.
In Sub-Saharan Africa, women constitute 59% of all people living with HIV/AIDS. Among young people aged 15-24, the HIV prevalence rate for young women is almost three times higher than the rate among young men.
Women and HIV
Women account for more than one in four new HIV/AIDS diagnoses and deaths caused by AIDS.
The proportion of AIDS diagnoses reported among women has more than tripled since 1985.
71% of women diagnosed with AIDS in 2005 contracted the disease through heterosexual sex.
African Americans constituted 66% of women diagnosed with HIV/AIDS in 2005.
In 2005, teen girls represented 43% of AIDS cases reported among people aged 13 to 19.
African Americans and Hispanics represent 24% of all women in the U.S. but they account for 82% of AIDS cases among women.
African-American women are 23 times more likely to have AIDS than white women.
AIDS is the leading cause of death for African-American women aged 25 to 34.
The proportion of AIDS diagnoses reported among women has more than tripled since 1985.
71% of women diagnosed with AIDS in 2005 contracted the disease through heterosexual sex.
African Americans constituted 66% of women diagnosed with HIV/AIDS in 2005.
In 2005, teen girls represented 43% of AIDS cases reported among people aged 13 to 19.
African Americans and Hispanics represent 24% of all women in the U.S. but they account for 82% of AIDS cases among women.
African-American women are 23 times more likely to have AIDS than white women.
AIDS is the leading cause of death for African-American women aged 25 to 34.
What is HIV?
Marriage Amongst Cousins
Kindly read through our frequently asked questions before submiting your queries. If you still wish to ask a question to our panel of experts, click here for our premium services.
Related Articles
Pre-Planning for your Pregnancy
Ovulation and Fertilization
more... Related FAQs
Conception Queries
Ideal Diet for Conception
Similar Blood Group
more... Discussion Boards
Marriage Amongst Cousins
Trying since long
more
How to Use a Spray Inhaler
How to Use a Spray Inhaler
Without a spacer
Take off the cap. Shake the inhaler.
Stand up. Breathe out.
Put the inhaler in your mouth or put it just in front of your mouth. As you start to breathe in, push down on the top of the inhaler and keep breathing in slowly.
Hold your breath for 10 seconds. Breathe out.
With a spacer
A spacer, or a holding chamber, makes it easier to use a spray inhaler.
Put the open end of the spacer in your mouth.
Spray the asthma medicine into the spacer one time.
Take a deep breath and hold it for 10 seconds.
Breathe out into the spacer.
Breathe in again, but do not spray the asthma medicine
What is asthma?
Asthma is a chronic, or long-term, disease. If you have asthma, at times your airways (the air passages of your lungs) become inflamed (see picture). When this happens, your airways get red and swollen. They become narrow, making it harder for you to breathe. You may also wheeze or cough. This is called an asthma flare-up (or "attack"). Even when you feel good, your airways can be inflamed. Certain things, such as smoke or dust, can start or trigger an asthma attack
Subscribe to:
Posts (Atom)